{"id":51634,"date":"2021-10-18T03:30:26","date_gmt":"2021-10-18T08:30:26","guid":{"rendered":"https:\/\/www.partnershipagainstcancer.ca\/?post_type=topics&p=51634"},"modified":"2025-12-23T13:56:26","modified_gmt":"2025-12-23T18:56:26","slug":"follow-up-colonoscopy-rate","status":"publish","type":"topics","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/follow-up-colonoscopy-rate\/","title":{"rendered":"Taux de coloscopie de suivi"},"content":{"rendered":"

Pourquoi est-ce important?<\/strong> \u2013 L\u2019efficacit\u00e9 d\u2019un programme de d\u00e9pistage exige que les personnes ayant obtenu un r\u00e9sultat anormal \u00e0 leur test f\u00e9cal subissent un examen de suivi diagnostique appropri\u00e9, sous la forme d\u2019une coloscopie, afin qu\u2019en fonction des r\u00e9sultats de ce nouvel examen, les \u00e9tapes suivantes puissent \u00eatre mises en \u0153uvre, avec comme objectif d\u2019optimiser les r\u00e9sultats pour ces personnes. La surveillance de cet indicateur fournit des renseignements importants en vue de planifier des strat\u00e9gies d\u2019am\u00e9lioration du suivi.<\/p>\n

D\u00e9finition de l\u2019indicateur<\/strong> : pourcentage de personnes qui, apr\u00e8s l\u2019obtention d\u2019un r\u00e9sultat anormal \u00e0 un test f\u00e9cal, ont subi une coloscopie de suivi dans un d\u00e9lai de six mois<\/p>\n

Cible<\/strong> : 85 % des personnes subissent une coloscopie de suivi dans un d\u00e9lai de six mois<\/p>\n

Calcul de l\u2019indicateur<\/strong><\/p>\n

Num\u00e9rateur : nombre de personnes qui, apr\u00e8s avoir obtenu un r\u00e9sultat anormal \u00e0 un test f\u00e9cal, ont subi une coloscopie de suivi dans un d\u00e9lai de six mois<\/p>\n

D\u00e9nominateur : nombre de personnes ayant obtenu un r\u00e9sultat anormal \u00e0 un test f\u00e9cal, durant la p\u00e9riode de mesure<\/p>\n

Comment la p\u00e9riode de 2017-2018 se compare-t-elle \u00e0 celle de 2013-2014?<\/strong> Comparativement aux donn\u00e9es du rapport sur le d\u00e9pistage du cancer colorectal pour 2013-2014, o\u00f9 le taux de suivi par coloscopie \u00e9tait de 62,9 \u00e0 82,8 %, le taux de suivi par coloscopie a augment\u00e9 dans la plupart des provinces et territoires en 2017-2018.
\n<\/a><\/p>\n

Pourcentage de recours \u00e0 une coloscopie dans les 180 jours suivant un r\u00e9sultat anormal \u00e0 un test f\u00e9cal, chez les personnes \u00e2g\u00e9es de 50 \u00e0 74 ans, par province et par territoire, pour les ann\u00e9es de d\u00e9pistage 2017 et 2018<\/h2>\n

\"diagramme<\/p>\n

Description textuelle et notes de bas de page<\/a><\/sub><\/p>\n

Le recours \u00e0 une coloscopie de suivi dans un d\u00e9lai de six mois apr\u00e8s un r\u00e9sultat anormal \u00e0 un test f\u00e9cal variait de 61,0 % en Nouvelle-\u00c9cosse \u00e0 95,8 % \u00e0 Terre-Neuve-et-Labrador. Le Manitoba (87,2 %) et Terre-Neuve-et-Labrador (95,8 %) avaient atteint la cible de 85 %, le Nouveau-Brunswick manquant de tr\u00e8s peu l\u2019objectif, \u00e0 84,5 %.<\/p>\n

Autres consid\u00e9rations<\/strong> : lors de l\u2019interpr\u00e9tation de cet indicateur, il est important de comprendre que la d\u00e9cision des patients de subir ou non une coloscopie de suivi ne d\u00e9pend pas uniquement de leur choix personnel, mais \u00e9galement des temps d\u2019attente<\/a>. Les personnes qui subissent une coloscopie de suivi plus de six mois apr\u00e8s avoir obtenu un r\u00e9sultat anormal \u00e0 un test f\u00e9cal ne sont pas prises en compte dans cet indicateur.<\/p>\n

Consid\u00e9rations sur la COVID-19<\/strong><\/p>\n

\"iconLes taux de coloscopie de suivi ont diminu\u00e9 pendant la pand\u00e9mie de COVID-19, les services de sant\u00e9 non urgents ayant \u00e9t\u00e9 suspendus ou r\u00e9duits1<\/sup>. Le taux de coloscopie de suivi est un indicateur que les programmes de d\u00e9pistage du cancer colorectal devront surveiller de pr\u00e8s, pendant la phase de r\u00e9tablissement de la COVID-19, afin de s\u2019assurer que les participants au d\u00e9pistage auront acc\u00e8s \u00e0 des services de coloscopie de suivi, en temps opportun, \u00e0 mesure que les retards seront r\u00e9sorb\u00e9s. Lorsque la proportion de personnes subissant une coloscopie de suivi dans un d\u00e9lai de six mois apr\u00e8s avoir obtenu un r\u00e9sultat anormal \u00e0 un test f\u00e9cal diminue, le nombre de cas de cancer colorectal diagnostiqu\u00e9s \u00e0 des stades avanc\u00e9s de la maladie augmente, avec des cons\u00e9quences sur les services de canc\u00e9rologie en aval du d\u00e9pistage, notamment une augmentation du nombre des interventions chirurgicales et des co\u00fbts th\u00e9rapeutiques.<\/p>\n

R\u00e9f\u00e9rence\u00a0<\/strong>
\n1 – Walker, M. J., Meggatto, O., Gao, J., Espino-Hernandez, G., Jembere, N. et coll. (2021). Measuring the impact of COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study. Preventive Medicine, DOI : https:\/\/doi.org\/10.1016\/j.ypmed.2021.106586<\/a>.<\/sub><\/p>\n","protected":false},"excerpt":{"rendered":"

Pourquoi est-ce important? \u2013 L\u2019efficacit\u00e9 d\u2019un programme de d\u00e9pistage exige que les personnes ayant obtenu un r\u00e9sultat anormal \u00e0 leur test f\u00e9cal subissent un examen de suivi diagnostique appropri\u00e9, sous la forme d\u2019une coloscopie, afin qu\u2019en fonction des r\u00e9sultats de ce nouvel examen, les \u00e9tapes suivantes puissent \u00eatre mises en \u0153uvre, avec comme objectif d\u2019optimiser […]<\/p>\n","protected":false},"author":24,"featured_media":0,"parent":51630,"menu_order":1,"template":"","topics_tags":[],"type-of-care":[],"cancer-continuum":[],"cancer-system-measurement":[],"dbt-cancer-site":[],"dbt-risk-factors":[],"dbt-population-characteristics":[],"class_list":["post-51634","topics","type-topics","status-publish","hentry"],"acf":[],"yoast_head":"\nCanadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/follow-up-colonoscopy-rate\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Taux de coloscopie de suivi - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"Pourquoi est-ce important? \u2013 L\u2019efficacit\u00e9 d\u2019un programme de d\u00e9pistage exige que les personnes ayant obtenu un r\u00e9sultat anormal \u00e0 leur test f\u00e9cal subissent un examen de suivi diagnostique appropri\u00e9, sous la forme d\u2019une coloscopie, afin qu\u2019en fonction des r\u00e9sultats de ce nouvel examen, les \u00e9tapes suivantes puissent \u00eatre mises en \u0153uvre, avec comme objectif d\u2019optimiser […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/follow-up-colonoscopy-rate\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-23T18:56:26+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/follow-up-colonoscopy-rate\\\/\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/follow-up-colonoscopy-rate\\\/\",\"name\":\"Taux de coloscopie de suivi - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/follow-up-colonoscopy-rate\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/follow-up-colonoscopy-rate\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/CRC-Graph-8-colonoscopy-FR.jpg\",\"datePublished\":\"2021-10-18T08:30:26+00:00\",\"dateModified\":\"2025-12-23T18:56:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/follow-up-colonoscopy-rate\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/follow-up-colonoscopy-rate\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/follow-up-colonoscopy-rate\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/CRC-Graph-8-colonoscopy-FR.jpg\",\"contentUrl\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/CRC-Graph-8-colonoscopy-FR.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/follow-up-colonoscopy-rate\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Topics\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/topics\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Surveillance et \u00e9valuation des indicateurs de la qualit\u00e9 du d\u00e9pistage du cancer colorectal\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Indicateurs\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Taux de coloscopie de suivi\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/follow-up-colonoscopy-rate\/","og_locale":"fr_FR","og_type":"article","og_title":"Taux de coloscopie de suivi - Canadian Partnership Against Cancer","og_description":"Pourquoi est-ce important? \u2013 L\u2019efficacit\u00e9 d\u2019un programme de d\u00e9pistage exige que les personnes ayant obtenu un r\u00e9sultat anormal \u00e0 leur test f\u00e9cal subissent un examen de suivi diagnostique appropri\u00e9, sous la forme d\u2019une coloscopie, afin qu\u2019en fonction des r\u00e9sultats de ce nouvel examen, les \u00e9tapes suivantes puissent \u00eatre mises en \u0153uvre, avec comme objectif d\u2019optimiser […]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/follow-up-colonoscopy-rate\/","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2025-12-23T18:56:26+00:00","twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/follow-up-colonoscopy-rate\/","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/follow-up-colonoscopy-rate\/","name":"Taux de coloscopie de suivi - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/follow-up-colonoscopy-rate\/#primaryimage"},"image":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/follow-up-colonoscopy-rate\/#primaryimage"},"thumbnailUrl":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2021\/09\/CRC-Graph-8-colonoscopy-FR.jpg","datePublished":"2021-10-18T08:30:26+00:00","dateModified":"2025-12-23T18:56:26+00:00","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/follow-up-colonoscopy-rate\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/follow-up-colonoscopy-rate\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/follow-up-colonoscopy-rate\/#primaryimage","url":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2021\/09\/CRC-Graph-8-colonoscopy-FR.jpg","contentUrl":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2021\/09\/CRC-Graph-8-colonoscopy-FR.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/follow-up-colonoscopy-rate\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Topics","item":"https:\/\/www.partnershipagainstcancer.ca\/topics\/"},{"@type":"ListItem","position":2,"name":"Surveillance et \u00e9valuation des indicateurs de la qualit\u00e9 du d\u00e9pistage du cancer colorectal","item":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/"},{"@type":"ListItem","position":3,"name":"Indicateurs","item":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/"},{"@type":"ListItem","position":4,"name":"Taux de coloscopie de suivi"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/51634","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/topics"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"up":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/51630"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=51634"}],"wp:term":[{"taxonomy":"topics_tags","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics_tags?post=51634"},{"taxonomy":"type-of-care","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/type-of-care?post=51634"},{"taxonomy":"cancer-continuum","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-continuum?post=51634"},{"taxonomy":"cancer-system-measurement","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-system-measurement?post=51634"},{"taxonomy":"dbt-cancer-site","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-cancer-site?post=51634"},{"taxonomy":"dbt-risk-factors","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-risk-factors?post=51634"},{"taxonomy":"dbt-population-characteristics","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-population-characteristics?post=51634"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}